Spravato REMS is the gate a clinic passes through before it can offer esketamine at all. The FDA requires it because of the drug's sedation, dissociation, and abuse risks, and it shapes far more than the first application: it defines who can administer the drug, where, how every session is monitored, and what has to be documented and submitted after each one.
Most clinics treat REMS certification as a form to complete once. In practice it is a standing operational commitment that touches scheduling, staffing, documentation, and billing on every single session. The clinics that struggle with it are rarely confused about the rules. They are missing an owner for the workflow the rules create.
This guide covers what the Spravato REMS program actually requires, what the two-hour monitoring record has to show, where compliance breaks down in day-to-day practice, and how to make the whole thing run without a dedicated compliance hire. The program was last modified by the FDA on October 9, 2025, so verify current requirements at spravatorems.com before relying on any summary, this one included.
What the Spravato REMS Program Requires
The program has a small number of moving parts, but each one carries an ongoing obligation. Per the official REMS program overview, the requirements break down like this:
| Requirement | What it means in practice | Who owns it |
|---|---|---|
| Healthcare setting certification | The site where Spravato is administered applies for certification, documenting the physical space, vital sign monitoring equipment, trained staff, and adverse event protocols | Clinic administrator or medical director, with a named backup |
| Patient enrollment | Every patient signs a one-time enrollment form with the provider before the first dose, confirming they understand the risks and monitoring requirements | Prescriber, verified at intake and scheduling |
| Two-hour monitoring | A healthcare provider stays onsite and monitors every patient for at least 2 hours after every dose: sedation, dissociation, respiratory depression, heart rate, blood pressure, and respiratory status including pulse oximetry | The monitoring clinician in the room |
| Patient Monitoring Form | Documented and submitted for every patient within 7 days of each administration | Monitoring clinician plus whoever owns the submission queue |
| Pharmacy certification | Pharmacies that dispense Spravato must also be certified in the program | The specialty pharmacy; confirm status before relying on them |
None of these are one-time events. Certification has to stay current, every new patient has to be enrolled before the first dose, and the monitoring plus form cycle repeats with every session the clinic runs.
The Two-Hour Window: What the Record Has to Show
After every dose, a healthcare provider must be onsite and monitor the patient for at least two hours for sedation, dissociation, respiratory depression, and changes in heart rate, blood pressure, and respiratory status, including pulse oximetry. The two hours are not a suggestion or an average. They are the floor, and the record has to demonstrate them.
A defensible monitoring record shows when the dose was administered, the observations made during the window, blood pressure checked before dosing and again around the 40-minute mark per the label, then as clinically warranted, and a clinician's confirmation that sedation and dissociation resolved before the patient left. A record with a start time and no discharge time cannot demonstrate a two-hour window, no matter how good the care in the room actually was.
If a patient insists on leaving before the window closes, document the early departure and the clinical context, and make sure the billing side reflects what actually happened. An incomplete observation billed as a complete session is exactly the kind of mismatch that surfaces later, a pattern we cover in our Spravato billing workflow guide.
The Patient Monitoring Form and Its 7-Day Deadline
A Patient Monitoring Form must be documented and submitted for every patient within 7 days of each administration. Not per patient, not per month: per session. A clinic running ten Spravato sessions a week owes the REMS program ten forms a week, each on its own clock.
This is the requirement that quietly falls behind. The clinical work is done, the note is in the EHR, and the form submission sits in someone's mental queue until the deadline passes. Treat the form like a claim: it has a due date, a owner, and a consequence for silence.
Where REMS Compliance Breaks Down in Practice
The failure modes are operational, not clinical:
- Certification loses its owner. The admin who set up the certification leaves, renewal correspondence goes to an unmonitored inbox, and the clinic keeps treating while its certified status quietly lapses. Give certification a named owner and a named backup, and put renewal on a recurring calendar, not in someone's memory.
- Enrollment is assumed instead of verified. A patient transfers in, or a second prescriber joins, and everyone assumes the enrollment form is on file. Verify enrollment at scheduling, before the first dose is on the calendar.
- The note is complete but the form is not submitted. EHR documentation and REMS form submission are two separate obligations. Completing one does not satisfy the other.
- Timestamps are missing. The observations happened, but the record shows no administration time or no departure time, so the two-hour window cannot be demonstrated after the fact.
These gaps rarely announce themselves on the day. They surface weeks later, when a payer reviews documentation against a claim, the same retrospective exposure we describe in our Spravato prior authorization guide. REMS compliance and clean billing stand on the same underlying record.
Making REMS Part of the Workflow, Not a Side Task
A clinic does not need a compliance department to run Spravato well. It needs four small systems:
- A named owner and backup for setting certification, with renewal on a recurring calendar
- An enrollment check built into scheduling, so no first dose gets booked without the signed form on file
- A monitoring template that captures the required fields every time: administration time, observations, blood pressure readings, resolution confirmation, departure time
- A tracked 7-day pipeline for Patient Monitoring Forms, managed with the same discipline as claim submissions
The common thread is documentation load, and that is where software genuinely helps. mdhub Clinical Assistant (Emma) takes the drafting and structuring work out of clinical documentation, and clinicians review and stay in control of every note. Teams using mdhub's AI assistants save 2+ hours per day, which is roughly what a Spravato session's monitoring and paperwork demand. On the revenue side, mdhub Billing Specialist (Eric) validates claims against the documentation before submission, so a REMS gap gets caught before it becomes a denial.
Streamline Your Practice
Spravato REMS asks four things of a clinic: stay certified, enroll every patient before the first dose, monitor and document every session for at least two hours, and submit a Patient Monitoring Form within 7 days of each administration. Every requirement is manageable. What clinics actually struggle with is running all four reliably while the rest of the practice keeps moving. If that is the gap in your clinic, the fix is workflow ownership plus documentation support, not more effort from already stretched staff. Book a demo with the mdhub team to see how clinics run Spravato programs without the paperwork backlog.
Three parties. The healthcare setting where Spravato is administered must be certified, which involves documenting the physical space, vital sign monitoring equipment, trained staff, and adverse event protocols. The pharmacy that dispenses the drug must also be certified. And each patient must be individually enrolled before their first dose, with a one-time form signed by both the patient and the provider confirming they understand the risks and the monitoring requirements. Verify all three are in place before the first session is scheduled, and confirm current requirements at spravatorems.com since the program was last modified in October 2025.
No. Under the REMS program, Spravato is administered only in a certified healthcare setting under the direct observation of a healthcare provider, and the patient is monitored onsite for at least two hours after every dose. The drug is never dispensed to a patient for home use. This is also why the treatment carries a real operational footprint for the clinic: every dose means a room, a monitoring clinician, and a two-hour block, which is worth planning for in scheduling and staffing before launching the service line.
Submit it as soon as the gap is found, and then fix the process that let it slip. A pattern of missing or late forms is a compliance exposure for the clinic's certified status and becomes visible whenever documentation is reviewed, including in payer audits that compare records against claims. The durable fix is treating form submission like claim submission: every session generates a form with a 7-day due date, the queue is tracked, and one person owns clearing it. If your clinic finds a backlog, clear it completely rather than only going forward, so the record is consistent.
